Deliberative process of health technology reassessment by health technology assessment agency in Korea

Int J Technol Assess Health Care. 2024 May 13;40(1):e28. doi: 10.1017/S026646232400014X.

Abstract

In 2019, the National Evidence-based Healthcare Collaborating Agency (NECA) in Korea established a health technology reassessment (HTR) system to manage the life cycle of health technologies and develop operational measures promoting the efficient use of healthcare resources. The purpose of this study is to introduce the detailed implementation process and practical functional methods of the HTR implemented by NECA.The HTR is a structured multidisciplinary method for analyzing health technologies currently used in the healthcare system based on the latest information on parameters, such as clinical safety, effectiveness, and cost-effectiveness of optimizing the use of healthcare resources as well as social and ethical issues. All decision-making stages of the HTR are carefully reviewed and transparently managed. The HTR committee makes significant decisions, and the subcommittee decides the details related to the assessment process.Since the pilot began in 2018, 262 cases have been reassessed, of which, 126 cases (48.1 percent) were health services not covered by the National Health Insurance (NHI). Over the past 5 years, approximately 130 recommendations for the in-use technologies were determined by the HTR committee. In the near future, it will be necessary to officially develop and establish a Korean HTR system and a legal foundation to optimize the NHI system.

Keywords: clinical safety; health insurance; health technology reassessment; in-use technology; recommendation; technology management.

MeSH terms

  • Cost-Benefit Analysis
  • Decision Making
  • National Health Programs / organization & administration
  • Republic of Korea
  • Technology Assessment, Biomedical* / organization & administration